Ridhi Parasrampuria

METEOR-1: A phase I study of GSK3326595, a first-in-class protein arginine methyltransferase 5 (PRMT5) inhibitor, in advanced solid tumours

L.L. Siu, Drew Rasco, S. P. Vinay et al. · Annals of Oncology · 2019 · 133 citations · Full text

Medicine, Oncology, Pharmacology +5

Phase <scp>II</scp> study results of a replacement therapy for hereditary angioedema with subcutaneous C1‐inhibitor concentrate

Bruce L. Zuraw, Marco Cicardi, Hilary Longhurst et al. · Allergy · 2015 · 76 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

Route‐dependent stereoselective pharmacokinetics of tramadol and its active<i>O</i>‐demethylated metabolite in rats

Ridhi Parasrampuria, Ragini Vuppugalla, Katherine J. Elliott et al. · Chirality · 2006 · 31 citations

Medicine, Pharmacokinetics, Pharmacology +14

Front-Loaded Linezolid Regimens Result in Increased Killing and Suppression of the Accessory Gene Regulator System of Staphylococcus aureus

Brian T. Tsuji, Tanya M. Brown, Ridhi Parasrampuria et al. · Antimicrobial Agents and Chemotherapy · 2012 · 31 citations · Full text

Life Sciences, Microbiology, Pharmacology +15

Stereospecific high-performance liquid chromatographic analysis of tramadol and its O-demethylated (M1) and N,O-demethylated (M5) metabolites in human plasma

Reza Mehvar, Katherine J. Elliott, Ridhi Parasrampuria et al. · Journal of Chromatography B · 2007 · 25 citations

Medicine, Pharmaceutical Analysis, Pharmacology +13